Novo Nordisk India Plans To Triple Staff Size In Four Years
This article was originally published in PharmAsia News
Executive Summary
Novo Nordisk India plans to expand its business in India by tripling its staff in four years and strengthening partnerships with Indian drug makers. The firm says the move is part of an effort to build its diabetes business. Novo Nordisk has joined with India's Torrent Pharma to provide strength in discovering and manufacturing new diabetes drugs. The firm now has more than 600 employees in India, but it wants to be a leader in the insulin business in a country that is considered the biggest for diabetes care. (Click here for more
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.